Karista — 2015 Investments

3 investments dated 2015 · listed companies and verified rows first · show all

Erytech Pharmaerytech.comDec 2015

BiotechLyon

Yann GODFRIN(Chief Scientific Officer, Co-Founder and Director)Gil BEYEN(Chief Executive Officer and Chairman of the Board)Martine GEORGE(Director)SVEN ANDREASSON(Legal representative of Galenos, SPRL, the director)Hilde WINDELS(Director)ERIC SOYER(Chief Financial Officer and Chief Operating Officer)

Co-investorsAndera Partners CapDecisif Management New Enterprise Associates (NEA)

Theracliontheraclion.com inJun 2015

Theraclion develops ultrasound-based medical devices for non-invasive treatment of vascular and thyroid conditions.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesRobotics

Michel Nuta(Executive Officer)in Sarah Ankri(Executive Officer)inSylvain Yon(Executive Officer)in Anja Kleber(Executive Officer)in David Caumartin(Executive Officer)in

BoardPhillippe Pouletty(Director)

Co-investorsCapDecisif Management

TRiCares GmbH and SAStricares.com inSeed · Sep 2015

TRiCares develops the Topaz Transfemoral Tricuspid Heart Valve Replacement (TTVR) System, a minimally invasive device for treating tricuspid regurgitation.

BiotechHardwareHealthtechMedical DevicesFrance, FR

Ahmed Elmouelhi(President & CEO)inEsther Gerteis(Senior VP Medical & Regulatory Affairs)inMichael Litzenburger(VP R&D)in

Co-investorsEuropean Investment Bank 415 Capital Andera Partners Bayern Kapital BioMedPartners CapDecisif Management

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.